Kevin Chow

University of Illinois Chicago — United States

Medicine · Health Sciences

15h-index2.2kcitations27works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(17), Immunotherapy and Immune Responses(10), Glioma Diagnosis and Treatment(6), Immune Cell Function and Interaction(4), Cancer Immunotherapy and Biomarkers(3)

Publications27 total

Predicting clinical outcomes among hospitalized COVID-19 patients using both local and published models
BMC Medical Informatics and Decision Making·2021· 17 citedOpen Access
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
Journal of Clinical Investigation·2021· 18 citedOpen Access
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
Journal of Clinical Investigation·2019· 28 citedOpen Access
Epidermal Growth Factor Receptor Mutation Status Confers Survival Benefit in Patients with Non-Small-Cell Lung Cancer Undergoing Surgical Resection of Brain Metastases: A Retrospective Cohort Study
World Neurosurgery·2019· 6 citedOpen Access
Immunotherapy for inoperable gliomas
Elsevier eBooks·2019
In Reply: Commentary: Peritumoral Edema/Tumor Volume Ratio: A Strong Survival Predictor for Posterior Fossa Metastases
Neurosurgery·2018· 1 cited
Commentary: Peritumoral Edema/Tumor Volume Ratio: A Strong Survival Predictor for Posterior Fossa Metastases
Neurosurgery·2018· 7 cited
DNA methylation analysis for the treatment of meningiomas
Journal of Visualized Surgery·2017· 7 citedOpen Access
IMMU-20. SELECTING AN EPHA2-CAR FOR THE IMMUNOTHERAPY OF DIPG AND GBM
Neuro-Oncology·2017Open Access
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
Journal of Clinical Investigation·2016· 657 citedOpen Access
HG-108MULTISPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS OVERCOME INTER-PATIENT TUMOR HETEROGENEITY AND EXHIBIT ENHANCED ANTITUMOR FUNCTIONALITY IN THE TREATMENT OF GLIOBLASTOMA
Neuro-Oncology·2016Open Access
A Bispecific Chimeric Antigen Receptor Molecule Enhances the Anti-Glioblastoma Efficacy of T Cells Through Dual Immunological Synapse Formation
Cytotherapy·2016
A bispecific chimeric antigen receptor molecule enhances T cell activation through dual immunological synapse formation and offsets antigen escape in glioblastoma
Journal for ImmunoTherapy of Cancer·2015· 8 citedOpen Access
Combining immunotherapy with radiation for the treatment of glioblastoma
Journal of Neuro-Oncology·2015· 18 cited
Genetic modification of T cells with a novel bispecific chimeric antigen receptor to enhance the control of high-grade glioma (HGG).
Journal of Clinical Oncology·2014· 9 cited
T cells redirected to interleukin-13Rα2 with interleukin-13 mutein–chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1
Cytotherapy·2014· 80 citedOpen Access
A bispecific chimeric antigen receptor targeting antigen escape variants in glioblastoma
Cytotherapy·2014· 1 cited
Current Vaccine Trials in Glioblastoma: A Review
Journal of Immunology Research·2014· 85 citedOpen Access
Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma
Molecular Therapy·2013· 367 citedOpen Access
Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
Molecular Therapy·2013· 332 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Stephen Gottschalk(17), Nabil Ahmed(12), Meenakshi Hegde(9), Vita S. Brawley(9), Tiara T. Byrd(9), Simone Krebs(9), Zakaria Grada(7), Malini Mukherjee(6), Amanda Wakefield(6), Kristen Fousek(6), Kevin Bielamowicz(6), Antonella Pignata(5), Winfried S. Wels(5), Matthew L. Baker(5), Gianpietro Dotti(5), Jordan S. Orange(5), Sunitha Kakarla(5), Zhongzhen Yi(5), Daniel Landi(4), Shoba A. Navai(4)